Imperial College London Featured PhD Programmes
University College London Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of Southampton Featured PhD Programmes
Cardiff University Featured PhD Programmes
"clinical" AND "trial"×
10 miles

Genetics (clinical trial) PhD Projects, Programs & Scholarships

We have 11 Genetics (clinical trial) PhD Projects, Programs & Scholarships

  • "clinical" AND "trial" ×
  • Genetics×
  • clear all
Order by 
Showing 1 to 10 of 11
  Patient experience of the Mesothelioma Stratified Therapy Trial (MiST): a qualitative study
  Prof A Tod, Dr B Taylor
Applications accepted all year round

Funding Type

PhD Type

This PhD provides a unique opportunity for a student to conduct a qualitative patient experience health services research study within a complex stratified clinical trial for people with malignant mesothelioma (MM), the Mesothelioma Stratified Therapy Trial (MiST).
  Evolutionary dynamics of MEK inhibitor sensitivity and resistance in diffuse midline glioma
  Dr C Jones, Dr O Rossanese
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  MRC DiMeN Doctoral Training Partnership: Investigating the mechanisms leading to CHK1 inhibitor resistance in cancer therapy
  Prof N Perkins, Prof S Rocha, Dr J Hunter
Application Deadline: 6 January 2020

Funding Type

PhD Type

DNA replication stress results from stalled DNA replication forks and is a feature of cancer cells, where it can lead to the genomic instability driving tumorigenesis.
  Identifying novel treatment options for ovarian carcinosarcoma
  Dr H Barker
Application Deadline: 31 January 2020

Funding Type

PhD Type

Location. The Walter and Eliza Hall Institute of Medical Research, University of Melbourne. Supervisors. Prof C. Scott, Dr H. Barker.
  PhD Research Fellow in Biomarker Discovery
  Prof G Alves, Dr J Maple-Grødem
Application Deadline: 17 November 2019

Funding Type

PhD Type

The University of Stavanger invites applicants for PhD fellowships in Biomedicine as part of the GCase-Responders Across Neurodegenerative Diseases (the GRAND project).
  MRC DiMeN Doctoral Training Partnership: How to kill a difficult superbug: understanding the evolution of antimicrobial resistance in Clostridioides difficile
  Dr R Fagan, Prof M Brockhurst
Application Deadline: 6 January 2020

Funding Type

PhD Type

Increasing resistance to antibiotics is one of the greatest health challenges facing humanity today. Clostridioides difficile is the primary cause of antibiotic-associated infections in UK hospitals and antibiotic-induced disruption of the gut microbiota is a prerequisite for infection.
  MRC DiMeN Doctoral Training Partnership: How to kill a difficult superbug: understanding the evolution of antimicrobial resistance in Clostridioides difficile
  Dr R Fagan, Prof M Brockhurst
Application Deadline: 6 January 2020

Funding Type

PhD Type

Increasing resistance to antibiotics is one of the greatest health challenges facing humanity today. Clostridioides difficile is the primary cause of antibiotic-associated infections in UK hospitals and antibiotic-induced disruption of the gut microbiota is a prerequisite for infection.
  TRANS-CASPS: Translational studies in Cedrianib in Alveolar Soft Part Sarcoma (CASPS) trial.
  Dr C Jones, Dr P Huang
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Molecular analysis of neutrophil extracellular traps (NETs) in rheumatoid arthritis
  Dr HL Wright, Prof RJ Moots
Applications accepted all year round

Funding Type

PhD Type

Neutrophil extracellular traps (NETs) kill pathogens via the release of chromatin and anti-microbial granule enzymes in an extracellular mesh or “net”.
  Oral vitamin D spray as a novel treatment for 22q11 deletion syndrome
  Dr A McNeill, Dr C Mazzà
Applications accepted all year round

Funding Type

PhD Type

22q11 deletion syndrome is the most common genetic disorder, affecting about 1/2500 people (as common as cystic fibrosis). It is due to a small missing piece of chromosome 22 on the long arm (q) at position 11.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.